Keyphrases
Acute Myocardial Infarction
30%
Adverse Drug Reaction
11%
AIMS™
11%
All-cause Mortality
21%
Amiodarone
10%
Aneurysm Size
11%
Angiotensin-converting Enzyme Inhibitor (ACEi)
17%
Aortic Root
11%
Aortopathy
11%
Atrial Fibrillation
30%
Atrial Natriuretic Factor
15%
Beta-blockers
17%
Brain Natriuretic Peptide
18%
Chronic Heart Failure
36%
Congestive Heart Failure
15%
Coronary Artery Disease
11%
Degradation Products
12%
Desmosine
62%
Elastin
38%
Elastin Degradation
29%
Endothelial Function
15%
Heart Failure
36%
Heart Failure Patients
14%
Heart Rate
11%
Hemoglobin A1c (HbA1c)
12%
Insulin Resistance
29%
Left Ventricular Dysfunction
11%
Left Ventricular Hypertrophy
16%
Left Ventricular Remodeling
11%
Loop Diuretics
13%
Marfan Syndrome
21%
Metformin
27%
Myocardial Infarction
12%
Natriuretic Peptides
12%
Non-diabetic
13%
Outcome Prediction
20%
Pathophysiology
13%
Patients with Coronary Artery Disease
16%
Patients with Heart Failure
36%
Placebo
21%
Plasma Parameters
20%
QT Prolongation
11%
Right Ventricular Pacing
12%
Root Length
10%
Ruptured Abdominal Aortic Aneurysm (rAAA)
16%
Scotland
16%
Sinus Rhythm
15%
Tayside
18%
Type 2 Diabetes Mellitus (T2DM)
22%
Type 2 Diabetic Patients
13%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
16%
Acute Heart Infarction
30%
Adverse Drug Reaction
10%
Adverse Outcome
8%
All Cause Mortality
17%
Amiodarone
10%
Aneurysm
10%
Angiotensin
22%
Angiotensin Receptor Antagonist
6%
Aortic Stenosis
11%
Atherosclerosis
9%
Atrial Fibrillation
30%
Atrial Natriuretic Factor
14%
Biological Marker
32%
Brain Natriuretic Peptide
20%
Cardiovascular Disease
10%
Carvedilol
7%
Cerebrovascular Accident
7%
Cohort Study
15%
Congestive Heart Failure
100%
Coronary Artery Disease
15%
Dapagliflozin
10%
Desmosine
40%
Diabetes Mellitus
20%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Diseases
9%
Elastin
28%
Endothelial Dysfunction
11%
Heart Infarction
13%
Heart Left Ventricle Failure
11%
Heart Left Ventricle Hypertrophy
12%
Heart Ventricle Remodeling
11%
Insulin Resistance
27%
Left Ventricular Systolic Dysfunction
9%
Loop Diuretic Agent
13%
Metformin
22%
Natriuretic Factor
10%
Non Insulin Dependent Diabetes Mellitus
17%
Normal Human
7%
Pathophysiology
6%
Placebo
26%
Prazosin
10%
Prevalence
7%
Pulmonary Hypertension
10%
QT Prolongation
10%
Randomized Controlled Trial
10%
Renin
24%
Statin (Protein)
11%
Syndrome X
10%
Warfarin
8%
Medicine and Dentistry
Abdominal Aortic Aneurysm
15%
Acute Heart Infarction
15%
Adipose Tissue
5%
Adverse Outcome
7%
Aneurysm
10%
Aortic Stenosis
6%
Aortopathy
10%
Apoplexy
6%
Atherosclerosis
7%
Atrial Fibrillation
15%
Atrial Natriuretic Factor
16%
Beta Adrenergic Receptor Blocking Agent
5%
Biological Marker
32%
Blood Pressure
6%
Brain Natriuretic Peptide
20%
Cardiac Dysrhythmia
8%
Cardiovascular Disease
12%
Cardiovascular Effect
10%
Cardiovascular System
15%
Congestive Heart Failure
48%
Coronary Artery Disease
21%
Cross Sectional Study
5%
Desmosine
30%
Diabetes
17%
Diabetes Mellitus
9%
Diseases
7%
Echocardiography
6%
Elastin
18%
Endothelial Dysfunction
8%
Endothelial Function
12%
Glycon
21%
Health Care Cost
5%
Heart Left Ventricle Failure
6%
Heart Muscle Perfusion
7%
Heart Output
11%
Insulin Resistance
25%
Left Ventricular Hypertrophy
15%
Loop Diuretic Agent
6%
Maturity Onset Diabetes of the Young
8%
Myocardial Infarction
5%
Natriuretic Factor
6%
Nitric Acid Derivative
5%
Pathophysiology
12%
Patient with Type 2 Diabetes
6%
Placebo
7%
Prevalence
6%
Randomized Controlled Trial
5%
Renin Angiotensin Aldosterone System
12%
Vasomotor
10%
Ventricle of Heart
7%
